Palladyne AI Corp.
For the period ended Sep 30, 2026. Filed Nov 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 10, 2026
PDYN$3.57+0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net (loss) income | $(36,947) | $11,532 |
| Adjustments to reconcile net (loss) income to net cash used in operating activities: | ||
| Stock-based compensation | 8,335 | 3,346 |
| Depreciation of property and equipment | 1,208 | 658 |
| Amortization of intangible assets | 1,066 | — |
| Change in fair value of warrant liabilities | (819) | (33,110) |
| Change in fair value of contingent consideration | 293 | — |
| Loss on disposal of assets | 27 | — |
| Amortization of investment discount | (598) | (1,065) |
| Changes in operating assets and liabilities, net of acquisitions: | ||
| Accounts receivable | (3,035) | (192) |
| Unbilled receivable | (58) | (640) |
| Inventories | (1,105) | (5) |
| Prepaid expenses and other current assets | 340 | 129 |
| Operating lease assets & other non-current assets | 784 | 925 |
| Accounts payable | 283 | 130 |
| Accrued liabilities and current operating lease liabilities | 2,941 | (100) |
| Operating lease liabilities | (894) | (740) |
| Net cash used in operating activities | (28,179) | (19,132) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (1,831) | (477) |
| Proceeds from sale of property and equipment | 100 | — |
| Purchases of marketable securities | (41,381) | (56,828) |
| Maturities of marketable securities | 51,000 | 37,000 |
| Net cash provided by (used in) investing activities | 7,888 | (20,305) |
| Cash flows from financing activities: | ||
| Proceeds from exercise of stock options | 278 | 65 |
| Proceeds from issuance of common stock under ESPP | 85 | 76 |
| Proceeds from the exercise of warrants | — | 6,419 |
| Payment of obligations under finance leases | (113) | — |
| Payment of equipment financing liabilities | (48) | — |
| Proceeds from issuance of common stock | 29,937 | 30,000 |
| Payment of offering costs related to issuance of common stock | (898) | (900) |
| Payment of transaction costs related to issuance of common stock | — | (50) |
| Net cash provided by financing activities | 29,241 | 35,610 |
| Net increase (decrease) in cash and cash equivalents | 8,950 | (3,827) |
| Cash and cash equivalents at beginning of period | 18,219 | 31,188 |
| Cash and cash equivalents at end of period | $27,169 | $27,361 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | $148 | $— |
| Supplemental disclosure of non-cash activities: | ||
| Operating lease right-of-use assets obtained in exchange for lease liabilities | $293 | $— |
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.